focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

Share Price Information for Kanabo Grp Plc (KNB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: -0.10 (-5.88%)
Spread: 0.20 (12.50%)
Open: 1.70
High: 1.60
Low: 1.60
Prev. Close: 1.70
KNB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 Jun 2022 17:02

RNS Number : 9033Q
Kanabo Group PLC
30 June 2022
 

 

Kanabo Group Plc.

Result of Annual General Meeting

 

Kanabo Group Plc is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed. The numbers of votes for each resolution are presented below:

 

 

 

Chairman of the meeting

FOR

Chairman of the meeting

AGAINST

 

 

 

 

Total Votes Cast

ABSTAIN

Resolution

 

No. of shares

%

No. of shares

%

1

Receive Financial Statements

115,542,133

99.75451

284,339

0.245487

115,826,472

142,706

2

Approve the Directors' Remuneration Report

115,458,280

99.69236

356,288

0.307637

115,814,568

154,610

3

Approve the re-appointment of the auditors and authorize the directors to determine the Auditors' Remuneration

115,553,226

99.75257

286,620

0.247428

115,839,846

129,332

4

Re-elect Andrew Morrison

113,469,744

97.99032

2,327,150

2.009683

115,796,894

172,284

5

Re-elect Avihu Israel Tamir

115,502,424

99.74567

294,510

0.254333

115,796,934

172,244

6

Re-elect David Tsur

115,508,799

99.75078

288,595

0.249224

115,797,394

171,784

7

Elect Daniel Poulter

115,509,839

99.75164

287,595

0.24836

115,797,434

171,744

8

Elect Gil Efron

115,509,839

99.75164

287,595

0.24836

115,797,434

171,744

9

Authorise the directors to allot securities

115,468,984

99.72081

323,278

0.279188

115,792,262

176,916

10*

Authorise the directors to allot Equity Securities

115,469,484

99.72081

323,278

0.279187

115,792,762

176,416

* Special Resolution

 

NOTES:

Votes "For" and "Against" are expressed as a percentage of votes received.

 

 

 

 

For further information, please visit http://www.kanabogroup.com/ or https://www.voxmarkets.co.uk/listings/LON/KNB or contact the following:

 

Kanabo Group Plc

Via Vox Markets

Avihu Tamir, CEO

 

Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Lauren Riley

 

Peterhouse Capital Ltd (Corporate Broker)

 

Lucy Williams / Charles Goodfellow

Duncan Vasey / Martin Lampshire

 

 

Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers.

 

The Company has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEASKEDSKAEFA
Date   Source Headline
4th Nov 20217:00 amRNSUpdate on Materia Acquisition
29th Oct 20217:00 amRNSTotal Voting Rights
22nd Oct 20217:00 amRNSHalf-year Report
7th Oct 20217:00 amRNSNew Partnership Agreement
30th Sep 20217:00 amRNSTotal Voting Rights
22nd Sep 20217:00 amRNSCBD Line Launched in the UK on HandpickedCBD.com
14th Sep 20217:05 amRNSMateria Receives Licence for Malta Facility
31st Aug 20211:51 pmRNSTotal Voting Rights
17th Aug 202111:05 amRNSSecond Price Monitoring Extn
17th Aug 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSUpdate: New contract signed by Materia
2nd Aug 20217:01 amRNSUpdate re: Investment & MoU with Hellenic Dynamics
30th Jul 202112:49 pmRNSTotal Voting Rights
26th Jul 202111:05 amRNSSecond Price Monitoring Extn
26th Jul 202111:00 amRNSPrice Monitoring Extension
26th Jul 20217:00 amRNSProposed Acquisition
22nd Jul 20213:32 pmRNSBlock Listing Application
14th Jul 20217:00 amRNSKanabo’s First Medical Cannabis Product in UK
8th Jul 20211:00 pmRNSIssue of Equity
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20217:00 amRNSAppointment of Director & Grant of Options
28th Jun 20213:41 pmRNSResult of AGM
25th Jun 20217:00 amRNSInitial Commercial Scale Production
24th Jun 20213:58 pmRNSIssue of Equity
17th Jun 20212:59 pmRNSIssue of Equity
4th Jun 20217:00 amRNSSupport for New Campaign
3rd Jun 202112:00 pmRNSNotice of AGM
2nd Jun 20219:26 amRNSAnnual Financial Report
26th May 20213:36 pmRNSAdmission of Placing Shares
24th May 20217:00 amRNSPlacing, Investment & MoU with Hellenic Dynamics
20th May 20217:00 amRNSNew EU GMP CBD Manufacturing Agreement
14th May 20212:00 pmRNSIssue of Equity
11th May 20211:09 pmRNSIssue of Equity
6th May 20212:00 pmRNSIssue of Equity
26th Apr 20213:03 pmRNSIssue of Equity
21st Apr 20212:57 pmRNSIssue of Equity
14th Apr 20214:01 pmRNSIssue of Equity
8th Apr 20213:15 pmRNSQ1 Summary
31st Mar 20214:51 pmRNSTotal Voting Rights
30th Mar 20213:26 pmRNSIssue of Equity
26th Mar 20217:00 amRNSPDMR Notification
23rd Mar 20218:47 amRNSPublication of Research Note
16th Mar 20212:42 pmRNSIssue of Equity
9th Mar 202111:06 amRNSSecond Price Monitoring Extn
9th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSMedicinal Cannabis Production Agreement
8th Mar 20213:42 pmRNSChange of Registered Address
23rd Feb 20217:00 amRNSUK Medicinal Cannabis Distribution Agreement
22nd Feb 20219:05 amRNSSecond Price Monitoring Extn
22nd Feb 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.